All posts by Arran Frood

Arran is currently a Freelance journalist for New Scientist, Nature, BBC Online, Focus,, The Lancet, The Independent, The Times, The Daily Telegraph,, The Khaleej Times, Nature Medicine, Chemistry & Industry. He also has experience with Nature Publishing Group and Science Photo Library and also works as a Digital Content Producer at BBSRC.

Mentors, mates or metrics: what are the alternatives to peer review?

You think that scientists, being quite clever people, would be able to agree on the best way to rank each other's work. Oh no, not any longer. For this article, the EuroScientist asked Science, Cell and Nature as well as eLife and independent commentators to go on the record with their thoughts on how they see the peer review system, as it stands, and what alternatives should be considered. Read more [...]

Open access in Europe: the bear and the tortoise

A little over decade from now, we may look back at the era when scientific research was locked up behind paywalls with curious fascination. How could it be that publicly funded research could be withheld from the very people that funded it, namely the taxpayer? How could access restricted even to the people that utilised it most, scientists? And how could a cabal of global publishers rake in billions in profit through activities they had little or no part in supporting financially? EuroScientist looks at the way the field has evolved in Europe. Read more [...]

Do science girls have an image problem?

Is the image of women scientists to blame for the lack of popularity of science studies? And how much could changing the image of female scientists do to solve the two problems that persist? Namely, boosting girls’ involvement in science from an early age. And removing the barriers to top positions for female scientists when they get there. Find out more in this EuroScientist article. Read more [...]

Should we turn a blind eye to science policy in Europe?

Should randomised controlled trials (RCTs) usually used in medicine to see if a new drug works be utilised across Europe through society-wide experiments to implement effective science policies? More than a hundred years ago, the journal Nature called for “a scientific approach to government” in a series of editorials calling for politicians to borrow the methods of science for the common good. Now, advocates of successful randomised controlled trials (RCTs) say the time has come to put aside the political rhetoric and see what actually works . Read more [...]

The psychology of Horizon 2020 budget cuts

Resisting a reduced spend on science in Europe may require decision makers to understand the mechanisms that makes them discount future benefits in return for short-term certainty on cost savings. Is it better to invest money now or save it for a rainy day? A dilemma faced by millions of people in the tough economic climate: invest now for an uncertain return in the long-term future, versus saving it for short-term needs. Read more [...]